Supplementary figures 1 and 2 for: Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Supplementary figures 1 and 2 for: Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

08/13/2021
By Centers for Disease Control and Prevention (U.S.)
Source: Tenforde MW, Self WH, Naioti EA, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1156-1162.
Series: MMWR. Morbidity and Mortality Weekly Report ; v. 70, early release, August 13, 2021

[PDF-160.99 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

cdc:108947,cdc:109825

Supplmentary figures for: Tenforde MW, Self WH, Naioti EA, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1156-1162.
Content Notes:

SUPPLEMENTARY FIGURE 1. Adjusted vaccine effectiveness* against COVID-19 hospitalization based on a natural cubic spline model among hospitalized adults by time since second dose of mRNA vaccine – 21 academic medical centers in 18 states,† March–July 2021. -- SUPPLEMENTARY FIGURE 2. Adjusted vaccine effectiveness* against COVID-19 hospitalizations based on a linear model among hospitalized adults by time since second dose of mRNA vaccine – 21 academic medical centers in 18 states, March–July 2021.
Subjects:

[+]

Adolescent Adult Aged CoronaVirus Infections COVID-19 COVID-19 Vaccines Female Hospitalization Humans Male Middle Aged Time Factors Vaccination Vaccines, Synthetic Young Adult
Source:

Tenforde MW, Self WH, Naioti EA, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1156-1162.
Series:

MMWR. Morbidity and Mortality Weekly Report ; v. 70, early release, August 13, 2021
Document Type:

Charts, Diagrams, Etc.
Name as Subject:

Janssen COVID-19 vaccine ; Moderna Covid-19 Vaccine ; Pfizer-BioNTech COVID-19 Vaccine ; Janssen COVID-19 vaccine ; Moderna Covid-19 Vaccine ; ... More +

Janssen COVID-19 vaccine ; Moderna Covid-19 Vaccine ; Pfizer-BioNTech COVID-19 Vaccine ; Janssen COVID-19 vaccine ; Moderna Covid-19 Vaccine ; Pfizer-BioNTech COVID-19 Vaccine Less -
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:9ebac3ed3955044dcfffdc1fa53933eec214e54702b0509541272927c9843664
Download URL:

https://stacks.cdc.gov/view/cdc/108758/cdc_108758_DS1.pdf
File Type:

No Additional Files

More +

Supplementary figures 1 and 2 for: Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

Details:

Supporting Files

You May Also Like